Dhruv Khullar
Dhruv Khullar is a contributing writer at The New Yorker covering medicine, health care, and politics. He is a practicing physician and an associate professor at Weill Cornell Medical College, where he serves as the director of the Physicians Foundation Center for the Study of Physician Practice and Leadership. He is also an associate director of the Cornell Health Policy Center. His research, which focusses on value-based care, health disparities, and medical innovation, has been published in JAMA and The New England Journal of Medicine. Khullar began his work in journalism in 2013, and has contributed to the New York Times, the Washington Post, and The Atlantic. He earned his medical degree from the Yale School of Medicine and completed his medical training at Massachusetts General Hospital. He also received a master’s degree in public policy from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership.
Can A.I. Find Cures for Untreatable Diseases—Using Drugs We Already Have?
For many medical conditions, lifesaving treatments may be hiding in plain sight.
How to Think About COVID-19 Vaccines in the Era of R.F.K., Jr.
The coronavirus may no longer be a leading danger to our health. That doesn’t mean it can’t hurt us, or that we don’t need to protect ourselves.
What to Make of Biden’s Prostate-Cancer Diagnosis
Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.
A Life-Changing Scientific Study Ended by the Trump Administration
Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s longest-running diabetes trials.
Dhruv Khullar on Oliver Sacks’s “The Case of Anna H.”
Wonder and observation propelled not only Sacks’s writing but also his doctoring. He wanted to chronicle even when he couldn’t cure.
Trump’s Agenda Is Undermining American Science
Research funded by the federal government has found useful expression in many of the defining technologies of our time. This Administration threatens that progress.
Investigating What Happens to the Body in Space
From the daily newsletter: a doctor goes to Mars. Plus: investigating celebrity yearbooks; Merve Emre on friendship books; and what will happen to the Department of Education?
Can the Human Body Endure a Voyage to Mars?
In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep space will make us sick.
Why Is the American Diet So Deadly?
A scientist tried to discredit the theory that ultra-processed foods are killing us. Instead, he overturned his own understanding of obesity.
The Gilded Age of Medicine Is Here
Health insurers and hospitals increasingly treat patients less as humans in need of care than consumers who generate profit.
The Fundamental Problem with R.F.K., Jr.,’s Nomination to H.H.S.
Kennedy has many bad ideas. Yet the irony of our political moment is that his more reasonable positions are the ones that could sink his candidacy.
Trump’s Health, and Ours
Studies increasingly suggest that a healthy nation depends on a healthy democracy.
Doctors Are Increasingly Worried About Biden
Nine physicians weighed in on the President’s health. Almost all were concerned that Biden’s symptoms might go beyond a gradual, aging-related decline.
Rise of the Nanomachines
Nanotechnology can already puncture cancer cells and drug-resistant bacteria. What will it do next?
Should We Be Worried About Bird Flu?
According to the C.D.C., the risk to public health remains low. But the country’s initial approach has had an unsettling resonance with the first months of COVID.
How to Die in Good Health
The average American celebrates just one healthy birthday after the age of sixty-five. Peter Attia argues that it doesn’t have to be this way.
How Joe Biden Could Address the Age Issue
In the battle to assuage anxieties about his fitness for office, the country’s oldest-ever sitting President has a powerful weapon at his disposal.
Will a Full-Body MRI Scan Help You or Hurt You?
Companies like Prenuvo and Ezra will use magnetic resonance imaging to reveal what’s inside you—for a price.
The Year of Ozempic
We may look back on new weight-loss drugs as some of the greatest advances in the annals of chronic disease.
Can A.I. Find Cures for Untreatable Diseases—Using Drugs We Already Have?
For many medical conditions, lifesaving treatments may be hiding in plain sight.
How to Think About COVID-19 Vaccines in the Era of R.F.K., Jr.
The coronavirus may no longer be a leading danger to our health. That doesn’t mean it can’t hurt us, or that we don’t need to protect ourselves.
What to Make of Biden’s Prostate-Cancer Diagnosis
Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.
A Life-Changing Scientific Study Ended by the Trump Administration
Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s longest-running diabetes trials.
Dhruv Khullar on Oliver Sacks’s “The Case of Anna H.”
Wonder and observation propelled not only Sacks’s writing but also his doctoring. He wanted to chronicle even when he couldn’t cure.
Trump’s Agenda Is Undermining American Science
Research funded by the federal government has found useful expression in many of the defining technologies of our time. This Administration threatens that progress.
Investigating What Happens to the Body in Space
From the daily newsletter: a doctor goes to Mars. Plus: investigating celebrity yearbooks; Merve Emre on friendship books; and what will happen to the Department of Education?
Can the Human Body Endure a Voyage to Mars?
In the coming years, an unprecedented number of people will leave planet Earth—but it’s becoming increasingly clear that deep space will make us sick.
Why Is the American Diet So Deadly?
A scientist tried to discredit the theory that ultra-processed foods are killing us. Instead, he overturned his own understanding of obesity.
The Gilded Age of Medicine Is Here
Health insurers and hospitals increasingly treat patients less as humans in need of care than consumers who generate profit.
The Fundamental Problem with R.F.K., Jr.,’s Nomination to H.H.S.
Kennedy has many bad ideas. Yet the irony of our political moment is that his more reasonable positions are the ones that could sink his candidacy.
Trump’s Health, and Ours
Studies increasingly suggest that a healthy nation depends on a healthy democracy.
Doctors Are Increasingly Worried About Biden
Nine physicians weighed in on the President’s health. Almost all were concerned that Biden’s symptoms might go beyond a gradual, aging-related decline.
Rise of the Nanomachines
Nanotechnology can already puncture cancer cells and drug-resistant bacteria. What will it do next?
Should We Be Worried About Bird Flu?
According to the C.D.C., the risk to public health remains low. But the country’s initial approach has had an unsettling resonance with the first months of COVID.
How to Die in Good Health
The average American celebrates just one healthy birthday after the age of sixty-five. Peter Attia argues that it doesn’t have to be this way.
How Joe Biden Could Address the Age Issue
In the battle to assuage anxieties about his fitness for office, the country’s oldest-ever sitting President has a powerful weapon at his disposal.
Will a Full-Body MRI Scan Help You or Hurt You?
Companies like Prenuvo and Ezra will use magnetic resonance imaging to reveal what’s inside you—for a price.
The Year of Ozempic
We may look back on new weight-loss drugs as some of the greatest advances in the annals of chronic disease.